Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
暂无分享,去创建一个
N. Geller | W. O’Neill | J. Joo | G. Zheng | E. Nabel | J. Goldstein | S. Ganesh | D. Holmes | R. Simari | Laxmi S. Mehta | K. Skelding | E. Billings | K. O'Neill | L. Mehta
[1] Patrick W Serruys,et al. Coronary-artery stents. , 2006, The New England journal of medicine.
[2] E. Nabel,et al. Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism. , 2004, The Journal of clinical investigation.
[3] M. Hellmich,et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types , 2004, The Pharmacogenomics Journal.
[4] Ash A. Alizadeh,et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.
[5] Patrick W Serruys,et al. Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study , 2004, Circulation.
[6] Hyun-Jai Cho,et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.
[7] L. Pease,et al. Having it both ways: MHC recognition in cis and trans , 2004, Nature Immunology.
[8] P. Serruys,et al. Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients , 2004, Circulation.
[9] D. Cohen,et al. Can we afford to eliminate restenosis? Can we afford not to? , 2004, Journal of the American College of Cardiology.
[10] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[11] F. Cipollone,et al. Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty , 2003, Circulation.
[12] Marjan S. Bolouri,et al. Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.
[13] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[14] Peter Libby. Bone marrow: a fountain of vascular youth? , 2003, Circulation.
[15] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[16] Ciro Indolfi,et al. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. , 2003, Trends in cardiovascular medicine.
[17] Rossella Fattori,et al. Drug-eluting stents in vascular intervention , 2003, The Lancet.
[18] Eric S. Lander,et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Baim,et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. , 2002, Journal of the American College of Cardiology.
[20] Joseph L. Gastwirth,et al. Trend Tests for Case-Control Studies of Genetic Markers: Power, Sample Size and Robustness , 2002, Human Heredity.
[21] K. Sugimachi,et al. Essential Role of Monocyte Chemoattractant Protein-1 in Development of Restenotic Changes (Neointimal Hyperplasia and Constrictive Remodeling) After Balloon Angioplasty in Hypercholesterolemic Rabbits , 2002, Circulation.
[22] E. Edelman,et al. Systemic Inflammation Induced by Lipopolysaccharide Increases Neointimal Formation After Balloon and Stent Injury in Rabbits , 2002, Circulation.
[23] P. Kemmeren,et al. Protein interaction verification and functional annotation by integrated analysis of genome-scale data. , 2002, Molecular cell.
[24] M. Makuuchi,et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.
[25] F. Welt,et al. Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted , 2002, Circulation research.
[26] H. Bergmeister,et al. Artery Balloon Angioplasty Model B Significantly Contributes to Lumen Loss in a Rabbit Iliac κ Activation of Nuclear Factor , 2002 .
[27] G. Condorelli,et al. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] Levon M Khachigian,et al. Coronary In-stent Restenosis: Current Status and Future Strategies , 2022 .
[29] M. Vidal,et al. Combined Functional Genomic Maps of the C. elegans DNA Damage Response , 2002, Science.
[30] J. Ott,et al. Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease , 2002, The Pharmacogenomics Journal.
[31] S. Dudoit,et al. STATISTICAL METHODS FOR IDENTIFYING DIFFERENTIALLY EXPRESSED GENES IN REPLICATED cDNA MICROARRAY EXPERIMENTS , 2002 .
[32] J. Ott,et al. Trimming, weighting, and grouping SNPs in human case-control association studies. , 2001, Genome research.
[33] G. Church,et al. Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae , 2001, Nature Genetics.
[34] D. Simon,et al. Leukocyte Integrin Mac-1 Recruits Toll/Interleukin-1 Receptor Superfamily Signaling Intermediates to Modulate NF-&kgr;B Activity , 2001, Circulation research.
[35] D. Schaid,et al. Case-Control Studies of Genetic Markers: Power and Sample Size Approximations for Armitage’s Test for Trend , 2001, Human Heredity.
[36] C. Morillo,et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. , 2001, Journal of the American College of Cardiology.
[37] R. Schwartz,et al. p27-p16 Fusion Gene Inhibits Angioplasty-Induced Neointimal Hyperplasia and Coronary Artery Occlusion , 2001, Circulation research.
[38] S. Marx,et al. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. , 2001, Circulation.
[39] P. Libby,et al. Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.
[40] F. Neumann,et al. Transcriptome Analysis Reveals a Role of Interferon-γ in Human Neointima Formation , 2001 .
[41] F Unger,et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.
[42] M. Makuuchi,et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis , 2001, Nature Medicine.
[43] J. Rossi,et al. Ribozyme-Mediated Inhibition of Rat Leukocyte-Type 12-Lipoxygenase Prevents Intimal Hyperplasia in Balloon-Injured Rat Carotid Arteries , 2001, Circulation.
[44] M. Reale,et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[45] J. Tanguay,et al. Recombinant Soluble P-Selectin Glycoprotein Ligand-1-Ig Reduces Restenosis Through Inhibition of Platelet-Neutrophil Adhesion After Double Angioplasty in Swine , 2001, Circulation.
[46] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[47] M. Vidal. A Biological Atlas of Functional Maps , 2001, Cell.
[48] L. Jakt,et al. Assessing clusters and motifs from gene expression data. , 2001, Genome research.
[49] G. Mintz,et al. Coronary in-stent restenosis - predictors, treatment and prevention. , 2000, European heart journal.
[50] M. Isobe,et al. Roles of P-Selectin in Inflammation, Neointimal Formation, and Vascular Remodeling in Balloon-Injured Rat Carotid Arteries , 2000, Circulation.
[51] J. Ott,et al. Selecting SNPs in two‐stage analysis of disease association data: a model‐free approach , 2000, Annals of human genetics.
[52] A. Diez-Juan,et al. Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease. , 2000, Frontiers in bioscience : a journal and virtual library.
[53] S. Kimmel,et al. A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention. , 2000, The American journal of cardiology.
[54] E. Nabel,et al. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. , 2000, Circulation.
[55] R. Rothenberg,et al. Ischemic heart disease , 2000 .
[56] M. Ziol,et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. , 2000, Circulation.
[57] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[58] E. Edelman,et al. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. , 2000, The Journal of clinical investigation.
[59] D. Holmes,et al. Coronary artery stents. , 2000, JAMA.
[60] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[61] G. Stone,et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.
[62] P. D. de Feyter,et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coro , 1999, Journal of the American College of Cardiology.
[63] V. Koteliansky,et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. , 1999, Circulation research.
[64] S Marx,et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. , 1999, Circulation.
[65] M. Yokoyama,et al. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53. , 1999, Circulation research.
[66] R. Virmani,et al. Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.
[67] E. Topol,et al. Frontiers in interventional cardiology. , 1998, Circulation.
[68] E. Nabel,et al. Expression of cyclin-dependent kinase inhibitors in vascular disease. , 1998, Circulation research.
[69] V. Lindner,et al. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. , 1997, Circulation.
[70] P. Sasieni. From genotypes to genes: doubling the sample size. , 1997, Biometrics.
[71] E. Braunwald,et al. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction. , 1997, The American journal of cardiology.
[72] P. Libby,et al. Restenosis revisited--new targets, new therapies. , 1997, The New England journal of medicine.
[73] P. Libby,et al. The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis* , 1997, The Journal of Biological Chemistry.
[74] V. Fuster,et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. , 1996, Circulation.
[75] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[76] E. Nabel,et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[77] P. Serruys,et al. Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curve. , 1996, Circulation.
[78] W. Weintraub,et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. , 1995, Circulation.
[79] P. Libby,et al. Sustained Activation of Vascular Cells and Leukocytes in the Rabbit Aorta After Balloon Injury , 1993, Circulation.
[80] S. Coughlin,et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. , 1993, The Journal of clinical investigation.
[81] E J Topol,et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.
[82] M A Hlatky,et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). , 1989, The American journal of cardiology.
[83] T. Ryan. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.
[84] F. Loop,et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.